citric acid, anhydrous has been researched along with Hypocalcemia in 48 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study was to determine if depth of halothane anesthesia contributed to the adverse cardiovascular effects of citrate-induced ionized hypocalcemia." | 7.67 | Depth of halothane anesthesia potentiates citrate-induced ionized hypocalcemia and adverse cardiovascular events in dogs. ( Cote', CJ, 1987) |
" calcium gluconate for treatment of hypocalcemia." | 3.76 | Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis. ( Adamski, J; Eisenmann, C; Griffin, AC; Milone, MC; Sachais, BS, 2010) |
"To describe our experience with a newly implemented RCA protocol with acid citrate dextrose formula A (ACD-A) and intravenous calcium gluconate, for use with PrismaFlex CRRT in critically ill patients with acute kidney injury." | 3.75 | Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy. ( Bailie, T; Burry, LD; Carvalhana, V; Hallett, D; Lapinsky, SE; Lee, D; Mehta, S; Ramganesh, S; Richardson, R; Tung, DD, 2009) |
"The purpose of this study was to determine if depth of halothane anesthesia contributed to the adverse cardiovascular effects of citrate-induced ionized hypocalcemia." | 3.67 | Depth of halothane anesthesia potentiates citrate-induced ionized hypocalcemia and adverse cardiovascular events in dogs. ( Cote', CJ, 1987) |
"Hypocalcemia was common but remained mild and asymptomatic." | 2.82 | Inpatient citrate-based hemodialysis in pediatric patients. ( Cutler, D; Fajardo, C; Sahney, S; Sanchez, CP; Sheth, R, 2016) |
"The goal of this observational retrospective study was to evaluate various donor and procedural variables as potential risk factors for different types of moderate to severe adverse events (AEs) during apheresis collections." | 2.46 | Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. ( Goldfinger, D; Lu, Q; Smeltzer, B; Yuan, S; Ziman, A, 2010) |
"Using predictive Q(Ca) dosing and integrating control of the infusion pumps with the dialysis machine, SLED-RCA can be near-automated today to provide a user-friendly and safe system." | 2.46 | Automated regional citrate anticoagulation: technological barriers and possible solutions. ( Frinak, S; Szamosfalvi, B; Yee, J, 2010) |
"Hypocalcemia was seen the least with RCE." | 1.48 | Regional citrate anticoagulation with calcium replacement in pediatric apheresis. ( Lee, J; Sigler, K; Srivaths, P, 2018) |
"One hundred twenty two consecutive ICU cancer patients with AKI treated with citrate-based CVVHD were prospectively evaluated in this prospective observational study." | 1.48 | Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury. ( Bezerra, JS; Burdmann, EA; Caires, RA; Costa E Silva, VT; Costalonga, EC; Fukushima, JT; Hajjar, LA; Oikawa, L; Oliveira Coelho, F; Oliveira, APL; Soares, CM, 2018) |
" An equation for estimating required citrate dose may allow revision of citrate dosing protocols." | 1.37 | Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. ( Brain, M; Brown, A; Fowler, P; Parkes, S; Robertson, I, 2011) |
" Citrate anticoagulation during single-needle hemodialysis, according to our protocol, is safe and effective." | 1.33 | Citrate anticoagulation for single-needle hemodialysis: safety and efficacy. ( Buturović-Ponikvar, J; Gubensek, J; Ponikvar, R, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (14.58) | 18.7374 |
1990's | 8 (16.67) | 18.2507 |
2000's | 17 (35.42) | 29.6817 |
2010's | 14 (29.17) | 24.3611 |
2020's | 2 (4.17) | 2.80 |
Authors | Studies |
---|---|
Robinson, A | 1 |
Rech, MA | 1 |
DeChristopher, PJ | 1 |
Vaughn, A | 1 |
Rubino, J | 1 |
Bannister, E | 1 |
Moore, ME | 1 |
Chang, K | 1 |
Maurizi-Balzan, J | 1 |
Jouve, T | 1 |
Naciri-Bennani, H | 1 |
Noble, J | 1 |
Tanoukhi, K | 1 |
Motte, L | 1 |
Malvezzi, P | 1 |
Rostaing, L | 1 |
Halpin, MR | 1 |
Chen, B | 1 |
Singer, RF | 1 |
Sigler, K | 1 |
Lee, J | 1 |
Srivaths, P | 1 |
Costa E Silva, VT | 1 |
Caires, RA | 1 |
Bezerra, JS | 1 |
Costalonga, EC | 1 |
Oliveira, APL | 1 |
Oliveira Coelho, F | 1 |
Fukushima, JT | 1 |
Soares, CM | 1 |
Oikawa, L | 1 |
Hajjar, LA | 1 |
Burdmann, EA | 1 |
Hunt, EA | 1 |
Jain, NG | 1 |
Somers, MJ | 1 |
Davis, TK | 1 |
Neumayr, T | 1 |
Geile, K | 1 |
Doctor, A | 1 |
Hmeil, P | 1 |
Slowinski, T | 1 |
Morgera, S | 1 |
Joannidis, M | 1 |
Henneberg, T | 1 |
Stocker, R | 1 |
Helset, E | 1 |
Andersson, K | 1 |
Wehner, M | 1 |
Kozik-Jaromin, J | 1 |
Brett, S | 1 |
Hasslacher, J | 1 |
Stover, JF | 1 |
Peters, H | 1 |
Neumayer, HH | 1 |
Kindgen-Milles, D | 1 |
Hegde, V | 1 |
Setia, R | 1 |
Soni, S | 1 |
Handoo, A | 1 |
Sharma, SK | 1 |
Chaudhary, D | 1 |
Kapoor, M | 1 |
Fajardo, C | 1 |
Sanchez, CP | 1 |
Cutler, D | 1 |
Sahney, S | 1 |
Sheth, R | 1 |
Callan, MB | 1 |
Appleman, EH | 1 |
Shofer, FS | 1 |
Mason, NJ | 1 |
Brainard, BM | 1 |
Groman, RP | 1 |
Burry, LD | 1 |
Tung, DD | 1 |
Hallett, D | 1 |
Bailie, T | 1 |
Carvalhana, V | 1 |
Lee, D | 1 |
Ramganesh, S | 1 |
Richardson, R | 1 |
Mehta, S | 1 |
Lapinsky, SE | 1 |
Yuan, S | 1 |
Ziman, A | 1 |
Smeltzer, B | 1 |
Lu, Q | 1 |
Goldfinger, D | 1 |
Morgan, DJ | 1 |
Ho, KM | 1 |
Szamosfalvi, B | 1 |
Frinak, S | 1 |
Yee, J | 1 |
Adamski, J | 1 |
Griffin, AC | 1 |
Eisenmann, C | 1 |
Milone, MC | 1 |
Sachais, BS | 1 |
Adamcewicz, M | 1 |
Bearelly, D | 1 |
Porat, G | 1 |
Friedenberg, FK | 1 |
Brain, M | 1 |
Parkes, S | 1 |
Fowler, P | 1 |
Robertson, I | 1 |
Brown, A | 1 |
Lee, G | 1 |
Arepally, GM | 1 |
Kishimoto, M | 1 |
Ohto, H | 1 |
Shikama, Y | 1 |
Kikuta, A | 1 |
Kimijima, I | 1 |
Takenoshita, S | 1 |
Mitchell, A | 1 |
Daul, AE | 1 |
Beiderlinden, M | 1 |
Schäfers, RF | 1 |
Heemann, U | 1 |
Kribben, A | 1 |
Peters, J | 1 |
Philipp, T | 1 |
Wenzel, RR | 1 |
WEIDNER, JG | 1 |
CLOWES, GH | 1 |
JENNINGS, ER | 1 |
BELAND, AJ | 1 |
COPE, JA | 1 |
ELLESTAD, MH | 1 |
MONROE, C | 1 |
SHADLE, OW | 1 |
Bueno, JL | 1 |
Barea, L | 1 |
García, F | 1 |
Castro, E | 1 |
Valbonesi, M | 2 |
Capra, C | 1 |
Frisoni, R | 1 |
Varinelli, I | 2 |
Burgstaler, EA | 1 |
Winters, JL | 2 |
Pineda, AA | 1 |
Buturović-Ponikvar, J | 1 |
Gubensek, J | 1 |
Ponikvar, R | 1 |
Fukuda, T | 3 |
Toyoshima, S | 3 |
Nakashima, Y | 3 |
Koshitani, O | 2 |
Kawaguchi, Y | 3 |
Momii, A | 1 |
Masumi, S | 1 |
Nakayama, M | 2 |
Harada, M | 1 |
Bell, AM | 1 |
Nolen, JD | 1 |
Knudson, CM | 1 |
Raife, TJ | 1 |
Hester, JP | 2 |
Mallette, LE | 1 |
Gomez, LS | 1 |
McCullough, J | 1 |
Mishler, JM | 1 |
Szymanski, IO | 1 |
Díaz, J | 1 |
Acosta, F | 1 |
Parrilla, P | 1 |
Sansano, T | 1 |
Contreras, RF | 1 |
Bueno, FS | 1 |
Martínez, P | 1 |
Davis, TM | 1 |
Singh, B | 1 |
Choo, KE | 1 |
Ibrahim, J | 1 |
Spencer, JL | 1 |
St John, A | 1 |
Schwarz, P | 3 |
Sørensen, HA | 2 |
McNair, P | 2 |
Transbøl, I | 3 |
Haden, ST | 1 |
Stoll, AL | 1 |
McCormick, S | 1 |
Scott, J | 1 |
Madsen, JC | 1 |
Rasmussen, AQ | 1 |
Brown, EM | 2 |
Downes, K | 1 |
Sarode, R | 1 |
Bruni, R | 1 |
Florio, G | 1 |
Marghero, A | 1 |
Telani, A | 1 |
Asai, T | 1 |
Shimizu, N | 1 |
Narita, M | 1 |
Kobayashi, M | 1 |
Liu, YC | 1 |
Shieh, JP | 1 |
Ho, ST | 1 |
Chang, P | 1 |
Tsou, SS | 1 |
Liu, SY | 1 |
Momsen, G | 1 |
Friis, T | 1 |
Gundberg, CM | 1 |
Grant, FD | 1 |
Conlin, PR | 1 |
Chen, CJ | 1 |
Johnson, PJ | 1 |
LeBoff, MS | 1 |
Bosakowski, T | 1 |
Levin, AA | 1 |
Cote', CJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Colon Preparation With 2-Litre Polyethylene Glycol (PEG) Split-dose in Combination With Lubiprostone Versus 4-Litre Polyethylene Glycol (PEG) Split-dose: a Randomized Controlled Trial[NCT04138004] | Phase 4 | 140 participants (Actual) | Interventional | 2019-12-01 | Completed | ||
Prismaflex Therapeutic Plasma Exchange: Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation[NCT04351438] | 108 participants (Actual) | Observational | 2012-01-31 | Active, not recruiting | |||
Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED Focused on the Prevention of RRT-related Hypophosphatemia and Optimization of Acid-base Balance: a Pilot Study[NCT03976440] | 30 participants (Anticipated) | Observational | 2019-06-01 | Active, not recruiting | |||
Citrate Effects and Role of Prophylactic Magnesium Administration During Large-Volume Leukapheresis[NCT00040235] | Phase 3 | 52 participants | Interventional | 2002-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for citric acid, anhydrous and Hypocalcemia
Article | Year |
---|---|
Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease.
Topics: Adolescent; Anticoagulants; Anxiety; Blood Component Removal; Blood Volume; Catheterization, Central | 2013 |
Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
Topics: Anticoagulants; Citric Acid; Critical Care; Humans; Hypocalcemia; Renal Replacement Therapy | 2014 |
Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arrhythmias, Cardiac; Blood Component Re | 2010 |
Automated regional citrate anticoagulation: technological barriers and possible solutions.
Topics: Anticoagulants; Automation; Bicarbonates; Calcium; Chelating Agents; Citric Acid; Equipment Design; | 2010 |
Mechanism of action and toxicities of purgatives used for colonoscopy preparation.
Topics: Ascorbic Acid; Calcium Phosphates; Cathartics; Citric Acid; Colonic Neoplasms; Colonoscopy; Humans; | 2011 |
Anticoagulation techniques in apheresis: from heparin to citrate and beyond.
Topics: Anticoagulants; Blood Component Removal; Calcium; Citric Acid; Hemorrhage; Heparin; Humans; Hypocalc | 2012 |
Complications of donor apheresis.
Topics: Blood Component Removal; Blood Donors; Calcification, Physiologic; Citric Acid; Embolism, Air; Human | 2006 |
Massive blood transfusion.
Topics: Blood Coagulation Disorders; Blood Component Transfusion; Child; Citric Acid; Humans; Hypocalcemia; | 2001 |
5 trials available for citric acid, anhydrous and Hypocalcemia
Article | Year |
---|---|
Inpatient citrate-based hemodialysis in pediatric patients.
Topics: Adolescent; Anticoagulants; Catheters; Child; Child, Preschool; Citric Acid; Female; Hemodialysis So | 2016 |
Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Topics: Acid-Base Equilibrium; Animals; Blood Donors; Blood Pressure; Calcium; Citric Acid; Dogs; Electrocar | 2008 |
Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers.
Topics: Adult; Anticoagulants; Citrates; Citric Acid; Electrocardiography; Female; Heart; Humans; Hypocalcem | 1995 |
Alterations in parathyroid dynamics in lithium-treated subjects.
Topics: Adult; Bipolar Disorder; Bone Density; Calcium; Citric Acid; Female; Humans; Hypocalcemia; Lithium; | 1997 |
Evidence for a role of intracellular stored parathyroid hormone in producing hysteresis of the PTH-calcium relationship in normal humans.
Topics: Adult; Calcium Chloride; Citric Acid; Female; Humans; Hypercalcemia; Hypocalcemia; Immunoradiometric | 1998 |
35 other studies available for citric acid, anhydrous and Hypocalcemia
Article | Year |
---|---|
Defining the optimal calcium repletion dosing in patients requiring activation of massive transfusion protocol.
Topics: Adult; Aged; Blood Transfusion; Calcium; Citric Acid; Female; Humans; Hypocalcemia; Male; Middle Age | 2023 |
[How to implement a complete apheresis program within a hemodialysis unit].
Topics: Blood Component Removal; Citric Acid; Diagnosis-Related Groups; Glucose; Health Services Needs and D | 2019 |
Efficacy, Safety, and Calcium Balance of an Accelerated Citrate Anticoagulated Membrane-Based Plasma Exchange Algorithm.
Topics: Algorithms; Anticoagulants; Calcium; Citric Acid; Humans; Hypocalcemia; Plasma Exchange; Prospective | 2022 |
Regional citrate anticoagulation with calcium replacement in pediatric apheresis.
Topics: Adolescent; Anticoagulants; Blood Component Removal; Calcium; Child; Child, Preschool; Citric Acid; | 2018 |
Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Calcium; Citric Acid; Critical Care; Critical Illness; El | 2018 |
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
Topics: Acid-Base Equilibrium; Acidosis; Aged; Alkalosis; Anticoagulants; Citric Acid; Female; Humans; Hypoc | 2015 |
Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity.
Topics: Adolescent; Adult; Calcium; Calcium Gluconate; Child; Child, Preschool; Citric Acid; Female; Hematop | 2016 |
Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
Topics: Acute Kidney Injury; Adult; Aged; Alkalosis; Anticoagulants; Calcium Gluconate; Citric Acid; Critica | 2009 |
Profound hypocalcaemia in a patient being anticoagulated with citrate for continuous renal replacement therapy.
Topics: Aged; Anticoagulants; Citric Acid; Humans; Hypocalcemia; Male; Renal Replacement Therapy; Rhabdomyol | 2009 |
Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis.
Topics: Calcium Gluconate; Citric Acid; Hematologic Neoplasms; Humans; Hypocalcemia; Kidney Function Tests; | 2010 |
Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.
Topics: Adult; Aged; Anticoagulants; Calcium; Citric Acid; Critical Illness; Drug Combinations; Female; Foll | 2011 |
Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Beverages; Blood Component Removal; Calcium | 2002 |
A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Calcium; Citric Acid; Female; Hemofiltration; Huma | 2003 |
The role of the kidney in hypocalcemia induced by citrate infusion.
Topics: Calcium; Citrates; Citric Acid; Hematologic Tests; Humans; Hypocalcemia; Kidney | 1960 |
CITRATE TOXICITY AND THE USE OF ANTICOAGULANT ACID CITRATE DEXTROSE BLOOD FOR EXTRACORPOREAL CIRCULATION.
Topics: Acidosis; Animals; Anticoagulants; Blood Preservation; Calcium Chloride; Child; Citrates; Citric Aci | 1965 |
A comparison of PLT collections from two apheresis devices.
Topics: Anticoagulants; Blood Donors; Blood Platelets; Citric Acid; Female; Glucose; Humans; Hypocalcemia; I | 2004 |
Discontinuous automated calcium supplementation during thrombocytapheresis with the MCS+ version C. Absence of severe complication due to calcium deprivation in 4308 procedures.
Topics: Anticoagulants; Automation; Blood Donors; Calcium Gluconate; Citric Acid; Drug Evaluation; Female; H | 2004 |
Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis.
Topics: Blood Donors; Citric Acid; Female; Humans; Hypocalcemia; Leukocyte Count; Male; Needles; Platelet Co | 2004 |
Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
Topics: Aged; Anticoagulants; Calcium Chloride; Catheters, Indwelling; Citric Acid; Female; Hemodialysis Sol | 2005 |
Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs.
Topics: Animals; Anticoagulants; Area Under Curve; Calcium; Citric Acid; Dogs; Dose-Response Relationship, D | 2006 |
Maximum acceptable infusion rate of citrate: relationship between blood ionized calcium levels and cardiovascular effects in anesthetized rats.
Topics: Animals; Area Under Curve; Blood Pressure; Calcium; Chelating Agents; Citric Acid; Dose-Response Rel | 2006 |
Effect of whole blood clotting time in rats with ionized hypocalcemia induced by rapid intravenous citrate infusion.
Topics: Animals; Calcium; Citric Acid; Hypocalcemia; Male; Rats; Rats, Sprague-Dawley; Whole Blood Coagulati | 2006 |
Severe citrate toxicity complicating volunteer apheresis platelet donation.
Topics: Adult; Blood Donors; Bumetanide; Citric Acid; Female; Humans; Hypertension; Hypocalcemia; Plateletph | 2007 |
Donor symptomatology and safety in blood cell separation procedures.
Topics: Adult; Aged; Blood Donors; Blood Platelets; Body Weight; Cell Separation; Citrates; Citric Acid; Emb | 1982 |
Systemic hypocalcemia after clinical injections of radiographic contrast media: amelioration by omission of calcium chelating agents.
Topics: Adult; Aged; Calcium; Citrates; Citric Acid; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Ede | 1983 |
Dosage regimens for citrate anticoagulants.
Topics: Anticoagulants; Blood Component Removal; Blood Donors; Body Constitution; Body Weight; Calcium Gluco | 1983 |
Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation.
Topics: Adult; Calcium; Calcium Chloride; Citrates; Citric Acid; Female; Humans; Hypocalcemia; Liver Transpl | 1995 |
Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Citrates; Citric Acid; Female; Humans; Hypercalcemia; Hypoc | 1993 |
Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C.
Topics: Anticoagulants; Automation; Blood Donors; Calcium Gluconate; Citric Acid; Drug Evaluation; Female; H | 2000 |
Calcium supplement increase on the second day of sequential two day leukapheresis.
Topics: Adult; Blood Donors; Calcium; Calcium Gluconate; Citric Acid; Female; Humans; Hypocalcemia; Leukaphe | 2001 |
Relationship between cardiovascular functions and ionic hypocalcemia induced by citrate infusion in anhepatic swines: CaCl2 therapy in severe ionic hypocalcemia.
Topics: Animals; Body Temperature; Calcium; Calcium Chloride; Carbon Dioxide; Chelating Agents; Citrates; Ci | 1992 |
Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study.
Topics: Adult; Citrates; Citric Acid; Diabetes Mellitus, Type 1; Female; Humans; Hypocalcemia; Male; Middle | 1992 |
Acute changes in serum osteocalcin during induced hypocalcemia in humans.
Topics: Adult; Citrates; Citric Acid; Humans; Hypocalcemia; Kinetics; Male; Osteocalcin; Parathyroid Hormone | 1991 |
Comparative acute toxicity of chlorocitrate and fluorocitrate in dogs.
Topics: Adenosine Triphosphate; Animals; Body Temperature; Citrates; Citric Acid; Citric Acid Cycle; Dogs; E | 1987 |
Depth of halothane anesthesia potentiates citrate-induced ionized hypocalcemia and adverse cardiovascular events in dogs.
Topics: Anesthesia, Inhalation; Animals; Citrates; Citric Acid; Dogs; Halothane; Hemodynamics; Hypocalcemia; | 1987 |